Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-21

Clinical Trial Update: Oxytocin and Eating [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating oxytocin for weight management/eating behavior, with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Yale-NUS College | Conditions: Weight Gain | Phase 2 | Status: UNKNOWN